Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease... Show more
Industry PharmaceuticalsGeneric
A.I.dvisor tells us that INDV and SUPN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and SUPN's prices will move in lockstep.
| Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
|---|---|---|---|---|
| INDV | 100% | N/A | ||
| SUPN - INDV | 30% Poorly correlated | N/A | ||
| EBS - INDV | 29% Poorly correlated | -0.82% | ||
| ALKS - INDV | 25% Poorly correlated | N/A | ||
| AMLX - INDV | 23% Poorly correlated | N/A | ||
| XERS - INDV | 22% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To INDV | 1D Price Change % |
|---|---|---|
| INDV | 100% | N/A |
| Pharmaceuticals: Generic industry (83 stocks) | 26% Poorly correlated | +1.78% |
INDV saw its Momentum Indicator move above the 0 level on June 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for INDV just turned positive on June 10, 2026. Looking at past instances where INDV's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
INDV moved above its 50-day moving average on June 03, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in of 205 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
INDV broke above its upper Bollinger Band on June 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for INDV entered a downward trend on June 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (147.059) is normal, around the industry mean (79.619). P/E Ratio (19.651) is within average values for comparable stocks, (97.708). INDV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.629). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. P/S Ratio (3.831) is also within normal values, averaging (96.435).